14 December 2022 in Nature
Myelin is required for the function of neuronal axons in the central nervous system, but the mechanisms that support myelin health are unclear. Although macrophages in the central nervous system have been implicated in myelin health1, it is unknown which macrophage populations are involved and which aspects they influence. Here we show that resident microglia are crucial for the maintenance of myelin health in adulthood in both mice and humans. We demonstrate that microglia are dispensable for developmental myelin ensheathment. However, they are required for subsequent regulation of myelin growth and associated cognitive function, and for preservation of myelin integrity by preventing its degeneration. We show that loss of myelin health due to the absence of microglia is associated with the appearance of a myelinating oligodendrocyte state with altered lipid metabolism. Moreover, this mechanism is regulated through disruption of the TGFβ1–TGFβR1 axis. Our findings highlight microglia as promising therapeutic targets for conditions in which myelin growth and integrity are dysregulated, such as in ageing and neurodegenerative disease2,3.
25 April 2019 in The Journal of Clinical Endocrinology & Metabolism
Background & Aims Enteroendocrine L cells release satiety inducing hormones in response to stimulation by luminal macronutrients. We sought to profile the differential impact of macronutrient type and site of release on circulating concentrations of the L cell derived enteroendocrine hormone Peptide Tyrosine Tyrosine (1-36) (PYY). Materials & Methods Eight healthy volunteers were recruited to a randomised, double-blinded, six-way crossover study. At each visit, participants consumed a 500 kilocalorie drink containing either carbohydrate, protein or fat, in either gastric or small intestinal release formulations. Plasma PYY concentrations and hunger ratings were assessed over 3 hours after consumption of the test drink. Food intake was recorded thereafter at an libitum lunch. Results Microcapsular formulations targeting the distal small intestinal delivery of fat, but not carbohydrate or protein, markedly enhance PYY release relative to macronutrient delivery in gastric release formulations. Food intake at an ad libitum meal was lowest following consumption of the formulation releasing fat at the distal small intestine. Conclusion Targeting of fat to the distal small intestine in delayed release microcapsules enhances PYY release and is associated with reductions in food intake.